Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded to “Hold” at Zacks Research

Reckitt Benckiser Group (OTCMKTS:RBGLY) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports.

A number of other equities research analysts have also recently weighed in on RBGLY. Kepler Capital Markets upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Friday, April 17th. Morgan Stanley upgraded Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a research report on Monday, March 16th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Reckitt Benckiser Group has an average rating of “Moderate Buy”.

Reckitt Benckiser Group Price Performance

Shares of RBGLY opened at $12.54 on Monday. Reckitt Benckiser Group has a twelve month low of $12.02 and a twelve month high of $17.80. The company has a debt-to-equity ratio of 0.98, a quick ratio of 0.63 and a current ratio of 0.85. The firm’s 50-day moving average is $12.92 and its two-hundred day moving average is $14.90.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.